IBERIABANK CORP - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
IBERIABANK CORP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2013$156,00010,0000.12%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2013
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 876,020$31,037,00013.97%
Private Capital Advisors, Inc. 173,191$6,136,0002.23%
ARDSLEY ADVISORY PARTNERS LP 265,000$9,389,0001.92%
SECTORAL ASSET MANAGEMENT INC 944,522$33,464,0001.61%
EMERALD MUTUAL FUND ADVISERS TRUST 446,824$15,830,0001.09%
KOPP INVESTMENT ADVISORS LLC 72,755$2,578,0000.95%
EMERALD ADVISERS, LLC 455,619$16,143,0000.91%
Cupps Capital Management, LLC 254,655$9,022,0000.58%
HealthCor Management, L.P. 300,000$10,629,0000.57%
EAM Investors, LLC 79,486$2,816,0000.56%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders